{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:34:33Z","timestamp":1794893673586,"version":"4.9.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) exhibits profound molecular heterogeneity and poor prognosis, necessitating novel tailored therapies. The basal and classical subtypes - driven by glycolysis versus lipid metabolism - have distinct prognostic implications warranting further characterization of their underlying transcriptional mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using spatial RNA sequencing we mapped PDAC molecular subtype heterogeneity, capturing spatially-resolved gene expression signatures and generating a comprehensive high-resolution dataset of 42,035 spatial spots. Subtype assignments were validated via multiplex immunofluorescence and quantitative analyses in patient-derived organoids and xenografts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our analysis resolved cancer cell signatures, deconvoluted intra-tumoral heterogeneity, and delineated an evolutional classical-to-basal trajectory. We identified metabolically \u2018hot\u2019, high-grade tumor niches characterized by concurrent enrichment of glycolysis and lipogenesis across both subtypes, nominating them as subtype-agnostic therapeutic targets. Preclinical models demonstrated that despite the basal subtype\u2019s glycolysis dependence, both classical and basal tumors are susceptible to glycolysis inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This work demonstrates that metabolic identity, spatial context, and tumor\u2013stroma crosstalk are an inseparable triad that drives PDAC behavior. Our findings show that aggressive metabolic tumor niches can be targeted by glycolysis inhibition in a subtype-agnostic manner, challenging the dogma of subtype-specific therapeutic silos and highlighting highly adaptable energetic niches as reservoirs that drive tumor progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-026-02628-3","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:03:48Z","timestamp":1774652628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-7170","authenticated-orcid":false,"given":"Alexandra Maria","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8164-9868","authenticated-orcid":false,"given":"Fabio Bennet","family":"G\u00e4tje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4312-4868","authenticated-orcid":false,"given":"Michelle Yi Ran","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teona","family":"Midelashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Robert","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Mittlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaida","family":"Hasanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz Leander","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Marie","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theon Robin","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanibal","family":"Bohnenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kueffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyris","family":"Papantonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Agorku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"R\u00fcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio El","family":"Yassouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwaran","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Warratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Igelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Planque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Maria","family":"Fendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2502-7897","authenticated-orcid":false,"given":"Tiago","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-1018","authenticated-orcid":false,"given":"Lena-Christin","family":"Conradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"1","key":"2628_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10\u201327.","journal-title":"World J Oncol"},{"issue":"1","key":"2628_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2628_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2628_CR4","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2628_CR5","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"1","key":"2628_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gutjnl-2017-314828","volume":"68","author":"L Huang","year":"2019","unstructured":"Huang L, et al. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. 2019;68(1):130\u20139.","journal-title":"Gut"},{"issue":"9414","key":"2628_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li D, et al. Pancreatic cancer. Lancet. 2004;363(9414):1049\u201357.","journal-title":"Lancet"},{"issue":"4","key":"2628_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/07853890.2018.1453168","volume":"50","author":"C Torres","year":"2018","unstructured":"Torres C, Grippo PJ. Pancreatic cancer subtypes: a roadmap for precision medicine. Ann Med. 2018;50(4):277\u201387.","journal-title":"Ann Med"},{"key":"2628_CR9","doi-asserted-by":"crossref","unstructured":"Krzyszczyk P, et al. The growing role of precision and personalized medicine for cancer treatment. Technol (Singap World Sci). 2018;6(3\u20134):79\u2013100.","DOI":"10.1142\/S2339547818300020"},{"issue":"4","key":"2628_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, et al. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16(4):207\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2628_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41598-019-56826-9","volume":"10","author":"F Dijk","year":"2020","unstructured":"Dijk F, et al. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems. Sci Rep. 2020;10(1):337.","journal-title":"Sci Rep"},{"issue":"1","key":"2628_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-017-0739-z","volume":"16","author":"DJ Birnbaum","year":"2017","unstructured":"Birnbaum DJ, et al. Validation and comparison of the molecular classifications of pancreatic carcinomas. Mol Cancer. 2017;16(1):168.","journal-title":"Mol Cancer"},{"issue":"7592","key":"2628_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352.","journal-title":"Nature"},{"issue":"10","key":"2628_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168\u201378.","journal-title":"Nat Genet"},{"issue":"2","key":"2628_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue M, et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet. 2020;52(2):231\u201340.","journal-title":"Nat Genet"},{"issue":"11","key":"2628_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/bjs\/znac272","volume":"109","author":"JA Suurmeijer","year":"2022","unstructured":"Suurmeijer JA, et al. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Br J Surg. 2022;109(11):1150\u20135.","journal-title":"Br J Surg"},{"issue":"5","key":"2628_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"2628_CR18","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020; 368(6487).","DOI":"10.1126\/science.aaw5473"},{"key":"2628_CR19","doi-asserted-by":"publisher","first-page":"1108776","DOI":"10.3389\/fphar.2022.1108776","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Li C, Liu Y. The role of metabolic reprogramming in pancreatic cancer chemoresistance. Front Pharmacol. 2022;13:1108776.","journal-title":"Front Pharmacol"},{"key":"2628_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2017.03.026","volume":"114","author":"C Grasso","year":"2017","unstructured":"Grasso C, Jansen G, Giovannetti E. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Crit Rev Oncol Hematol. 2017;114:139\u201352.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"19","key":"2628_CR21","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1158\/1078-0432.CCR-17-1151","volume":"23","author":"V Gunda","year":"2017","unstructured":"Gunda V, et al. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017;23(19):5881\u201391.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2628_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015;162(6):1229\u201341.","journal-title":"Cell"},{"issue":"1","key":"2628_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19(1):50.","journal-title":"Mol Cancer"},{"issue":"11","key":"2628_CR24","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","volume":"56","author":"AM Khaliq","year":"2024","unstructured":"Khaliq AM, et al. Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nat Genet. 2024;56(11):2455\u201365.","journal-title":"Nat Genet"},{"issue":"5","key":"2628_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell. 2025;43(5):905\u2013e9246.","journal-title":"Cancer Cell"},{"issue":"1","key":"2628_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12967-024-05307-3","volume":"22","author":"J Zhu","year":"2024","unstructured":"Zhu J, et al. Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer. J Translational Med. 2024;22(1):563.","journal-title":"J Translational Med"},{"issue":"9","key":"2628_CR27","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","volume":"43","author":"M-M Chen","year":"2025","unstructured":"Chen M-M, et al. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell. 2025;43(9):1656\u2013e167610.","journal-title":"Cancer Cell"},{"issue":"8066","key":"2628_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","volume":"642","author":"G Pei","year":"2025","unstructured":"Pei G, et al. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature. 2025;642(8066):212\u201321.","journal-title":"Nature"},{"issue":"817","key":"2628_CR29","doi-asserted-by":"publisher","first-page":"eady7524","DOI":"10.1126\/scitranslmed.ady7524","volume":"17","author":"ATF Bell","year":"2025","unstructured":"Bell ATF, et al. Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion. Sci Transl Med. 2025;17(817):eady7524.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2628_CR30","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1038\/s41467-023-39026-y","volume":"14","author":"C Saillard","year":"2023","unstructured":"Saillard C, et al. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma. Nat Commun. 2023;14(1):3459.","journal-title":"Nat Commun"},{"issue":"3","key":"2628_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1158\/0008-5472.CAN-22-3050","volume":"83","author":"HL Williams","year":"2023","unstructured":"Williams HL, et al. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity. Cancer Res. 2023;83(3):441\u201355.","journal-title":"Cancer Res"},{"issue":"4","key":"2628_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/path.6398","volume":"265","author":"M Hilmi","year":"2025","unstructured":"Hilmi M, et al. Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach. J Pathol. 2025;265(4):448\u201361.","journal-title":"J Pathol"},{"key":"2628_CR33","doi-asserted-by":"publisher","unstructured":"Cannoodt R et al. SCORPIUS improves trajectory inference and identifies novel modules in dendritic cell development. bioRxiv. 2016; p. 079509. https:\/\/doi.org\/10.1101\/079509.","DOI":"10.1101\/079509"},{"issue":"1","key":"2628_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","volume":"37","author":"J Goveia","year":"2020","unstructured":"Goveia J, et al. An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates. Cancer Cell. 2020;37(1):21\u201336. e13.","journal-title":"Cancer Cell"},{"key":"2628_CR35","doi-asserted-by":"publisher","unstructured":"Sergushichev AA. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv. 2016; p. 060012. https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"},{"key":"2628_CR36","doi-asserted-by":"publisher","unstructured":"KorotkevichG et al. Fast gene set enrichment analysis. bioRxiv. 2021; p. 060012. https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"},{"issue":"7","key":"2628_CR37","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2628_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi L, et al. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018;36(5):421\u20137.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2628_CR39","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/bioinformatics\/btx657","volume":"34","author":"T Galili","year":"2018","unstructured":"Galili T, et al. heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics. 2018;34(9):1600\u20132.","journal-title":"Bioinformatics"},{"key":"2628_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2628_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, et al. Organoid Models of Human and Mouse Ductal Pancreatic Cancer. Cell. 2015;160(1):324\u201338.","journal-title":"Cell"},{"issue":"1","key":"2628_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13402-024-00958-2","volume":"48","author":"N Ferreira","year":"2025","unstructured":"Ferreira N, et al. OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data. Cell Oncol (Dordr). 2025;48(1):101\u201322.","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"2628_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.gastro.2023.10.026","volume":"166","author":"MC Hasselluhn","year":"2024","unstructured":"Hasselluhn MC, et al. An NFATc1\/SMAD3\/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. Gastroenterology. 2024;166(2):298\u2013e31214.","journal-title":"Gastroenterology"},{"issue":"5","key":"2628_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","volume":"24","author":"P Horak","year":"2022","unstructured":"Horak P, et al. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med. 2022;24(5):986\u201398.","journal-title":"Genet Med"},{"issue":"1","key":"2628_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19(1):4\u201323.","journal-title":"J Mol Diagn"},{"issue":"2","key":"2628_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2478\/bjmg-2018-0022","volume":"21","author":"D A","year":"2018","unstructured":"A D, et al. The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy. Balkan J Med Genet. 2018;21(2):21\u20136.","journal-title":"Balkan J Med Genet"},{"issue":"1","key":"2628_CR47","doi-asserted-by":"publisher","first-page":"p1911","DOI":"10.1038\/s41598-022-05841-4","volume":"12","author":"A Kinkhabwala","year":"2022","unstructured":"Kinkhabwala A, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12(1):p1911.","journal-title":"Sci Rep"},{"issue":"8","key":"2628_CR48","doi-asserted-by":"publisher","first-page":"104659","DOI":"10.1016\/j.isci.2022.104659","volume":"25","author":"R Chijimatsu","year":"2022","unstructured":"Chijimatsu R, et al. Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. iScience. 2022;25(8):104659.","journal-title":"iScience"},{"key":"2628_CR49","doi-asserted-by":"publisher","unstructured":"DeOliveira T et al. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo. Cancers (Basel). 2021;13(5). https:\/\/doi.org\/10.3390\/cancers13051011.","DOI":"10.3390\/cancers13051011"},{"issue":"6","key":"2628_CR50","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","volume":"30","author":"AR Cantelmo","year":"2016","unstructured":"Cantelmo AR, et al. Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy. Cancer Cell. 2016;30(6):968\u201385.","journal-title":"Cancer Cell"},{"issue":"1","key":"2628_CR51","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/s41467-023-42402-3","volume":"14","author":"C-L Chiang","year":"2023","unstructured":"Chiang C-L, et al. Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer. Nat Commun. 2023;14(1):6692.","journal-title":"Nat Commun"},{"issue":"3","key":"2628_CR52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93(3):491\u2013507.","journal-title":"Biometrika"},{"issue":"30","key":"2628_CR53","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1038\/s41388-021-01864-9","volume":"40","author":"J Li","year":"2021","unstructured":"Li J, et al. SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer. Oncogene. 2021;40(30):4884\u201393.","journal-title":"Oncogene"},{"key":"2628_CR54","doi-asserted-by":"publisher","first-page":"p8159537","DOI":"10.1155\/2022\/8159537","volume":"2022","author":"F Xiong","year":"2022","unstructured":"Xiong F, et al. Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma. Dis Markers. 2022;2022:p8159537.","journal-title":"Dis Markers"},{"issue":"7","key":"2628_CR55","doi-asserted-by":"publisher","first-page":"e40157","DOI":"10.1371\/journal.pone.0040157","volume":"7","author":"JM Winter","year":"2012","unstructured":"Winter JM, et al. A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS ONE. 2012;7(7):e40157.","journal-title":"PLoS ONE"},{"issue":"3","key":"2628_CR56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13273-021-00207-9","volume":"18","author":"YY Peng","year":"2022","unstructured":"Peng YY, et al. FXYD3 promotes the proliferation, migration, and invasion of pancreatic cancer cells by regulating the cGMP-PKG signaling pathway. Mol Cell Toxicol. 2022;18(3):371\u201381.","journal-title":"Mol Cell Toxicol"},{"issue":"11","key":"2628_CR57","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.18632\/oncotarget.23929","volume":"9","author":"D Hu","year":"2018","unstructured":"Hu D, et al. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget. 2018;9(11):9789\u2013807.","journal-title":"Oncotarget"},{"issue":"12","key":"2628_CR58","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1080\/21645515.2021.2003645","volume":"17","author":"S Ota","year":"2021","unstructured":"Ota S, et al. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and\/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy. Hum Vaccin Immunother. 2021;17(12):5563\u201372.","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"2628_CR59","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/1535-7163.MCT-21-0368","volume":"20","author":"SD Markov","year":"2021","unstructured":"Markov SD, et al. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021;20(12):2457\u201368.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2628_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41181-023-00204-4","volume":"8","author":"A Hull","year":"2023","unstructured":"Hull A, et al. In vitro characterisation of [(177)Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer. EJNMMI Radiopharm Chem. 2023;8(1):18.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"24","key":"2628_CR61","doi-asserted-by":"publisher","first-page":"E4714","DOI":"10.1073\/pnas.1619473114","volume":"114","author":"A Oberhofer","year":"2017","unstructured":"Oberhofer A, et al. Myosin Va\u2019s adaptor protein melanophilin enforces track selection on the microtubule and actin networks in vitro. Proc Natl Acad Sci U S A. 2017;114(24):E4714\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2628_CR62","doi-asserted-by":"publisher","unstructured":"Li WS et al. Overexpression of MLPH in Rectal Cancer Patients Correlates with a Poorer Response to Preoperative Chemoradiotherapy and Reduced Patient Survival. Diagnostics (Basel). 2021;11(11). https:\/\/doi.org\/10.3390\/diagnostics11112132.","DOI":"10.3390\/diagnostics11112132"},{"issue":"7","key":"2628_CR63","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jid.2019.12.023","volume":"140","author":"D Guo","year":"2020","unstructured":"Guo D, et al. RAB27A\/Melanophilin Blocker Inhibits Melanoma Cell Motility and Invasion. J Invest Dermatol. 2020;140(7):1470\u2013e14733.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"2628_CR64","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/sj.bjc.6602113","volume":"91","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, et al. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer. 2004;91(7):1384\u201390.","journal-title":"Br J Cancer"},{"issue":"6","key":"2628_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"2628_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40169-016-0106-5","volume":"5","author":"V Ribas","year":"2016","unstructured":"Ribas V, Garcia-Ruiz C, Fernandez-Checa JC. Mitochondria, cholesterol and cancer cell metabolism. Clin Transl Med. 2016;5(1):22.","journal-title":"Clin Transl Med"},{"key":"2628_CR67","volume-title":"Pancreatic Cancer and Tumor Microenvironment","author":"ZA Rasheed","year":"2012","unstructured":"Rasheed ZA, Matsui W, Maitra A. Pathology of pancreatic stroma in PDAC. In: Grippo PJ, Munshi HG, editors. Pancreatic Cancer and Tumor Microenvironment. Editors: Trivandrum; 2012. (India)."},{"key":"2628_CR68","doi-asserted-by":"publisher","first-page":"1595523","DOI":"10.3389\/fonc.2025.1595523","volume":"15","author":"X Zhu","year":"2025","unstructured":"Zhu X, et al. FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K\/AKT signaling. Front Oncol. 2025;15:1595523.","journal-title":"Front Oncol"},{"issue":"7","key":"2628_CR69","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/MPA.0000000000000409","volume":"44","author":"J Vaz","year":"2015","unstructured":"Vaz J, et al. SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer. Pancreas. 2015;44(7):1024\u201335.","journal-title":"Pancreas"},{"issue":"6","key":"2628_CR70","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3892\/ol.2021.12746","volume":"21","author":"K Pan","year":"2021","unstructured":"Pan K, Huang X, Jia X. SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu. Oncol Lett. 2021;21(6):485.","journal-title":"Oncol Lett"},{"issue":"1","key":"2628_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3835(02)00517-7","volume":"190","author":"LW Qian","year":"2003","unstructured":"Qian LW, et al. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett. 2003;190(1):105\u201312.","journal-title":"Cancer Lett"},{"issue":"6","key":"2628_CR72","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","volume":"161","author":"P Nallasamy","year":"2021","unstructured":"Nallasamy P, et al. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis. Gastroenterology. 2021;161(6):1998\u20132013. e7.","journal-title":"Gastroenterology"},{"issue":"1","key":"2628_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41540-023-00320-6","volume":"9","author":"G Avsar","year":"2023","unstructured":"Avsar G, Pir P. An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. NPJ Syst Biol Appl. 2023;9(1):56.","journal-title":"NPJ Syst Biol Appl"},{"key":"2628_CR74","first-page":"609948","volume":"11","author":"JT Noe","year":"2020","unstructured":"Noe JT, Mitchell RA. MIF-Dependent Control Tumor Immun Front Immunol. 2020;11:609948.","journal-title":"MIF-Dependent Control Tumor Immun Front Immunol"},{"issue":"5","key":"2628_CR75","first-page":"3531","volume":"19","author":"P Chen","year":"2020","unstructured":"Chen P, et al. Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells. Oncol Lett. 2020;19(5):3531\u201341.","journal-title":"Oncol Lett"},{"issue":"1","key":"2628_CR76","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41598-025-87337-5","volume":"15","author":"M Zardab","year":"2025","unstructured":"Zardab M, et al. AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility. Sci Rep. 2025;15(1):2934.","journal-title":"Sci Rep"},{"issue":"1","key":"2628_CR77","doi-asserted-by":"publisher","first-page":"16133","DOI":"10.1038\/s41598-025-88265-0","volume":"15","author":"C Wu","year":"2025","unstructured":"Wu C, et al. Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. Sci Rep. 2025;15(1):16133.","journal-title":"Sci Rep"},{"issue":"4","key":"2628_CR78","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ymthe.2020.12.029","volume":"29","author":"D Thomas","year":"2021","unstructured":"Thomas D, et al. Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer. Mol Ther. 2021;29(4):1557\u201371.","journal-title":"Mol Ther"},{"issue":"1","key":"2628_CR79","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.onc.1207013","volume":"23","author":"ML Voz","year":"2004","unstructured":"Voz ML, et al. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene. 2004;23(1):179\u201391.","journal-title":"Oncogene"},{"issue":"7","key":"2628_CR80","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.7150\/jca.90689","volume":"15","author":"P Chen","year":"2024","unstructured":"Chen P, et al. MicroRNA-485-5p targets keratin17 to regulate pancreatic cancer cell proliferation and invasion via the FAK \/ SRC \/ ERK pathway. J Cancer. 2024;15(7):2033\u201344.","journal-title":"J Cancer"},{"key":"2628_CR81","doi-asserted-by":"publisher","unstructured":"Murthy D, Attri KS. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2023;24(8). https:\/\/doi.org\/10.3390\/ijms24087304.","DOI":"10.3390\/ijms24087304"},{"issue":"15","key":"2628_CR82","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1038\/s41388-020-1207-6","volume":"39","author":"T Wang","year":"2020","unstructured":"Wang T, et al. PTGES\/PGE(2) signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model. Oncogene. 2020;39(15):3179\u201394.","journal-title":"Oncogene"},{"issue":"1","key":"2628_CR83","doi-asserted-by":"publisher","first-page":"26111","DOI":"10.1038\/s41598-025-11495-9","volume":"15","author":"C Shen","year":"2025","unstructured":"Shen C, Zhuo J, Wang J. The effect of PDLIM7 on cell proliferation, migration, and drug sensitivity in clear cell renal cell carcinoma. Sci Rep. 2025;15(1):26111.","journal-title":"Sci Rep"},{"issue":"1","key":"2628_CR84","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1476-4598-12-120","volume":"12","author":"D Weissinger","year":"2013","unstructured":"Weissinger D, et al. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma. Mol Cancer. 2013;12(1):120.","journal-title":"Mol Cancer"},{"key":"2628_CR85","doi-asserted-by":"publisher","first-page":"695740","DOI":"10.3389\/fonc.2021.695740","volume":"11","author":"R Li","year":"2021","unstructured":"Li R, et al. TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1. Front Oncol. 2021;11:695740.","journal-title":"Front Oncol"},{"issue":"1","key":"2628_CR86","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13046-019-1252-6","volume":"38","author":"C Xu","year":"2019","unstructured":"Xu C, et al. beta-Catenin nuclear localization positively feeds back on EGF\/EGFR-attenuated AJAP1 expression in breast cancer. J Exp Clin Cancer Res. 2019;38(1):238.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2628_CR87","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00018-024-05442-6","volume":"81","author":"W Jiang","year":"2024","unstructured":"Jiang W, et al. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. Cell Mol Life Sci. 2024;81(1):417.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2628_CR88","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3892\/ijo.2015.3167","volume":"47","author":"H Tanaka","year":"2015","unstructured":"Tanaka H, et al. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus. Int J Oncol. 2015;47(5):1811\u20138.","journal-title":"Int J Oncol"},{"issue":"17","key":"2628_CR89","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/onc.2015.289","volume":"35","author":"HJ Li","year":"2016","unstructured":"Li HJ, et al. NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition. Oncogene. 2016;35(17):2266\u201378.","journal-title":"Oncogene"},{"issue":"3","key":"2628_CR90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/scientificamerican0307-50","volume":"296","author":"FS Collins","year":"2007","unstructured":"Collins FS, Barker AD. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am. 2007;296(3):50\u20137.","journal-title":"Sci Am"},{"issue":"6","key":"2628_CR91","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1053\/j.gastro.2024.07.016","volume":"167","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Cancer-Associated Endocrine Cells Participate in Pancreatic Carcinogenesis. Gastroenterology. 2024;167(6):1167\u2013e118223.","journal-title":"Gastroenterology"},{"key":"2628_CR92","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.tranon.2023.101692","volume":"33","author":"M Dong","year":"2023","unstructured":"Dong M, et al. Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDAC. Transl Oncol. 2023;33:101692.","journal-title":"Transl Oncol"},{"issue":"1","key":"2628_CR93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi A, et al. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat Cancer. 2020;1(1):59\u201374.","journal-title":"Nat Cancer"},{"issue":"32","key":"2628_CR94","doi-asserted-by":"publisher","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","volume":"112","author":"A Daemen","year":"2015","unstructured":"Daemen A, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci U S A. 2015;112(32):E4410\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2628_CR95","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1038\/s41467-018-06287-x","volume":"9","author":"NMS Gustafsson","year":"2018","unstructured":"Gustafsson NMS, et al. Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination. Nat Commun. 2018;9(1):3872.","journal-title":"Nat Commun"},{"key":"2628_CR96","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi L, et al. Roles of PFKFB3 in cancer. Signal Transduct Target Ther. 2017;2:17044.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2628_CR97","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cmet.2019.01.015","volume":"29","author":"S Schworer","year":"2019","unstructured":"Schworer S, Vardhana SA, Thompson CB. Cancer Metabolism Drives a Stromal Regenerative Response. Cell Metab. 2019;29(3):576\u201391.","journal-title":"Cell Metab"},{"issue":"12","key":"2628_CR98","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","volume":"15","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786\u2013801.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2628_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12957-019-1574-z","volume":"17","author":"D Hu","year":"2019","unstructured":"Hu D, et al. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma. World J Surg Oncol. 2019;17(1):29.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"2628_CR100","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1053\/j.gastro.2016.06.005","volume":"151","author":"S Heeg","year":"2016","unstructured":"Heeg S, et al. ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. Gastroenterology. 2016;151(3):540\u2013e55314.","journal-title":"Gastroenterology"},{"issue":"2","key":"2628_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pan.2017.12.014","volume":"18","author":"R Shintakuya","year":"2018","unstructured":"Shintakuya R, et al. The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine in combination with S-1 or adjuvant gemcitabine alone. Pancreatology. 2018;18(2):191\u20137.","journal-title":"Pancreatology"},{"issue":"6","key":"2628_CR102","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.celrep.2014.08.029","volume":"8","author":"DT Ting","year":"2014","unstructured":"Ting DT, et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep. 2014;8(6):1905\u201318.","journal-title":"Cell Rep"},{"issue":"1","key":"2628_CR103","doi-asserted-by":"publisher","first-page":"17412","DOI":"10.1038\/s41598-024-68109-z","volume":"14","author":"E Li","year":"2024","unstructured":"Li E, Cheung HCZ, Ma S. CTHRC1(+) fibroblasts and SPP1(+) macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma. Sci Rep. 2024;14(1):17412.","journal-title":"Sci Rep"},{"issue":"8","key":"2628_CR104","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/1878-0261.12073","volume":"11","author":"VL Veenstra","year":"2017","unstructured":"Veenstra VL, et al. Stromal SPOCK1 supports invasive pancreatic cancer growth. Mol Oncol. 2017;11(8):1050\u201364.","journal-title":"Mol Oncol"},{"issue":"1","key":"2628_CR105","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.isci.2024.111572","volume":"28","author":"N Ohri","year":"2025","unstructured":"Ohri N, et al. Gene expression dynamics in fibroblasts during early-stage murine pancreatic carcinogenesis. iScience. 2025;28(1):111572.","journal-title":"iScience"},{"issue":"11","key":"2628_CR106","doi-asserted-by":"publisher","first-page":"e50078","DOI":"10.15252\/embr.202050078","volume":"21","author":"R Melchionna","year":"2020","unstructured":"Melchionna R, et al. The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer\/stromal cell cooperation. EMBO Rep. 2020;21(11):e50078.","journal-title":"EMBO Rep"},{"key":"2628_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-017-0004-7","volume":"4","author":"V Gouirand","year":"2018","unstructured":"Gouirand V, Vasseur S. Fountain of youth of pancreatic cancer cells: the extracellular matrix. Cell Death Discov. 2018;4:1.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2628_CR108","doi-asserted-by":"publisher","first-page":"15598","DOI":"10.1038\/s41598-024-65900-w","volume":"14","author":"T Shibayama","year":"2024","unstructured":"Shibayama T, et al. Combination immunohistochemistry for CK5\/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naive pancreatic ductal adenocarcinoma. Sci Rep. 2024;14(1):15598.","journal-title":"Sci Rep"},{"issue":"11","key":"2628_CR109","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly J, et al. Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Cancer Discov. 2024;14(11):2135\u201361.","journal-title":"Cancer Discov"},{"issue":"1","key":"2628_CR110","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41392-025-02499-y","volume":"11","author":"E Rozengurt","year":"2026","unstructured":"Rozengurt E, Eibl G. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Therapy. 2026;11(1):6.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"2628_CR111","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, et al. IL1-Induced JAK\/STAT Signaling Is Antagonized by TGFbeta to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2019;9(2):282\u2013301.","journal-title":"Cancer Discov"},{"issue":"5","key":"2628_CR112","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s13402-025-01100-6","volume":"48","author":"J Wu","year":"2025","unstructured":"Wu J, et al. Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression. Cell Oncol. 2025;48(5):1571\u201392.","journal-title":"Cell Oncol"},{"issue":"8","key":"2628_CR113","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.108618","volume":"21","author":"Y Wu","year":"2025","unstructured":"Wu Y, et al. Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression. Int J Biol Sci. 2025;21(8):3573\u201396.","journal-title":"Int J Biol Sci"},{"key":"2628_CR114","doi-asserted-by":"publisher","unstructured":"Wu H et al. Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer. iScience. 2025;28(6). https:\/\/doi.org\/10.1016\/j.isci.2025.112681.","DOI":"10.1016\/j.isci.2025.112681"},{"issue":"1","key":"2628_CR115","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-020-03319-7","volume":"12","author":"A K\u00fcper","year":"2021","unstructured":"K\u00fcper A, et al. Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis. Cell Death Dis. 2021;12(1):82.","journal-title":"Cell Death Dis"},{"key":"2628_CR116","doi-asserted-by":"crossref","unstructured":"Liu Y, et al. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1\/AKT\/mTOR axis. Volume 13. Cell Death & Disease; 2022. p. 232. 3.","DOI":"10.1038\/s41419-022-04669-0"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02628-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:01:18Z","timestamp":1781643678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02628-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02628-3","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the UMG Ethics Committee, G\u00f6ttingen, Germany (Nr. 25\/3\/17) and informed consent and was collected from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors David Agorku, Silvia R\u00fcberg and Fabio El Yassouri are employees of Miltenyi Biotec B.V. & Co. KG, while all other authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}